<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339225</id>
  <title nil="true"/>
  <common-name>N-(8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)-5-bromo-2-methoxy-4-[(2,2,2-trifluoroacetyl)amino]benzamide</common-name>
  <description>N-(8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)-5-bromo-2-methoxy-4-[(2,2,2-trifluoroacetyl)amino]benzamide is a chemical compound with the formula C24H25BrF3N3O3. With an average molecular weight of 540.40 g/mol, N-(8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)-5-bromo-2-methoxy-4-[(2,2,2-trifluoroacetyl)amino]benzamide is a heavy molecule.</description>
  <cas>76352-06-2</cas>
  <pubchem-id>3059378</pubchem-id>
  <chemical-formula>C24H25BrF3N3O3</chemical-formula>
  <weight>540.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T22:29:40Z</created-at>
  <updated-at type="dateTime">2026-08-30T22:29:40Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(=C(C=C1C(=O)NC2CC3CCC(C2)N3CC4=CC=CC=C4)Br)NC(=O)C(F)(F)F</moldb-smiles>
  <moldb-formula>C24H25BrF3N3O3</moldb-formula>
  <moldb-inchi>InChI=1S/C24H25BrF3N3O3/c1-34-21-12-20(30-23(33)24(26,27)28)19(25)11-18(21)22(32)29-15-9-16-7-8-17(10-15)31(16)13-14-5-3-2-4-6-14/h2-6,11-12,15-17H,7-10,13H2,1H3,(H,29,32)(H,30,33)</moldb-inchi>
  <moldb-inchikey>JCHMDCXVBBMOAS-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">539.10314</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.9</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335118</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>N-(8-benzyl-8-azabicyclo[3.2.1]octan-3-yl)-5-bromo-2-methoxy-4-[(2,2,2-trifluoroacetyl)amino]benzamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Piperidines</klass>
  <subklass>Benzylpiperidines</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289647</sync-id>
  <structure-inchikey>JCHMDCXVBBMOAS-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>80000000200000000000004000000000000000000040000080000000000000002008000000001c000000000000000000010002200000000000000000000000000000000000000020001000002100000000800000000000000000010000404040000000100000000000020100000000000000000000100000000040200000820000000000000080000000008100000080000002000000000800000004000080000000080000000000000000040000000000000000000080000000000000000800000120000000000410000000000000000220240000000000008000000000000840000000020410800000000020000100000000000040</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJQAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:46Z</structure-indexed-at>
</compound>
